Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03190837 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Long-term Follow-up Study of Gaucher Disease

StatusRecruiting
PhaseNot specified
Started2017-06-12
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Jan 2027 → Jan 2028
See other at-risk trials from Duke University

Amendment history

2026-09-01
Study Status, Oversight v10
Primary completion pushed: 2027-01 → 2028-01
Completion pushed: 2027-01 → 2028-01
2025-09-16
8 amendments v2-v9
8 re-verifications since 2018-10-19, no change to tracked fields
2017-07-25
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2017-06→confirmed 2017-06-12
Study sites0→1
2017-06-15
Original filing
Duke University
455 trials monitored
See 53 trials at risk
The study aims are to: a) identify the long-term natural history of Gaucher disease, b) evaluate long-term treatment efficacy of enzyme replacement therapy (ERT) and substrate reduction therapy (SRT), and c) identify potential long-term complications of this disorder. These aims will be accomplished through long-term record review of individuals with all three types of Gaucher disease.
Trial Details
NCT Number NCT03190837
Lead Sponsor Duke University
Conditions Gaucher Disease
Enrollment 200 participants
Start Date 2017-06-12
Primary Completion 2028-01 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2026-09-03